EUFMD 

Research Group 2000

Report

Appendix 01

Appendix 02

Appendix 03

Appendix 04

Appendix 05

Appendix 06

Appendix 07

Appendix 08

Appendix 09

Appendix 10

Appendix 11

Appendix 12

Appendix 13

Appendix 14

Appendix 15

Appendix 16

Appendix 17

Appendix 18

Appendix 19

Appendix 20

Appendix 21

Appendix 22

Appendix 23

Appendix 24

Appendix 25

Appendix 26

Appendix 27

Appendix 28

Appendix 29

Appendix 30

Appendix 31

Appendix 32

Appendix 33

Appendix 34

Appendix 35

Appendix 36

Appendix 37

Appendix 38

Appendix 39

Report of the Session of the Research Group of the Standing Technical Committee of EUFMD

Borovets, Bulgaria

5 to 8 September 2000

The report itself can be found here.

The following is the List of Appendices

Appendix 01 - Emergence of a Pandemic Strain of Foot-and-Mouth Disease Virus Serotype O, Nick J. Knowles; Alan R. Samuel; Paul R. Davies; R. Paul Kitching; R. Venkataramanan; Toru Kanno; Alexei V. Scherbakov; Vladimir V.Drygin; Qi-Zu Zhao and Qing-Ge Xie.

Appendix 02 - Pathogenicity of O/JPN/2000 to susceptible animals, Kenichi Sakamoto; Makoto Yamakawa; Toru Kanno and Yosuke Murakami.

Appendix 03 - Origin of recent outbreaks in North africa the Middle East and Europe, Nick J. Knowles.

Appendix 04 - FMD situation in Turkey in 2000, Ismet Gurhan.

Appendix 05 - Minimal aerosol infectious dose of the 01 Lausanne strain of foot-and-mouth disease virus for pigs, Soren Alexandersen; Ian Brotherhood and Alex I. Donaldson.

Appendix 06 - Antigenic and genetic characterization of foot-and-mouth disease type O viruses from the Far East, A.R. Samuel; L.S. Turner and N.J. Knowles.

Appendix 07 - Genetically diverse isolates of type O foot-and-mouth disease virus exhibit remarkable amino acid conservation at their neutralizing antigenic sites, A.R. Samuel.

Appendix 08 - Early pathogenesis of foot-and-mouth disease in pigs: a quantitative time-course study using a newly developed TaqMan RT-PCR assay, Soren Alexandersen; Martin B. Oleksiewicz and Alex I. Donaldson.

Appendix 09 - IgA response of cattle to FMDV infection in probing and saliva samples, Amadori M.; Haas B.; Moos A.; and Zerbini I..

Appendix 10 - Guidelines for the control and eradication of foot-and-mouth disease in livestock populations with a high density of sheep, Alex I. Donaldson.

Appendix 11 - Possible introduction of FMD with sheep intestines from FMD countries, Bernd Haas and Matthias Kramer.

Appendix 12 - Peculiarities of FMD buffer zone functioning in the CIS countries, V.M. Avilov; V.M. Zakharov; A.A. Gusev; S.A. Doudnikov; N.A. Yariomenko; A.M. Rakhmanov; A.K. Karaulov.

Appendix 13 - Results of seromonitoring studies in FMD buffer zone of the CIS countries, T.A. Fomina; V.M. Zakharov; A.A. Gusev; N.Y. Kamalova; S.R. Kremenchugskaya; O.A. Schekotova.

Appendix 14 - Sensitivity of primary cells immortalized by oncogene transfection for the isolation of foot-and-mouth disease virus, M.P. Ferris; G.M. Hutchings;H.J. Moulsdale; J.B.Clarke.

Appendix 15 - Interferon and foot-and-mouth disease virus, Reinhard Ahl. (Fig 1-4, Fig 5-7, Fig 8-10, Legend of figures, Tables 1-2-3)

Appendix 16 - Type-independent detection of foot-and-mouth disease virus by ELISA using monoclonal antibodies that bind to the animoterminus of capsid protein VP2, Brigitte Freiberg; Bernd Haas; Barbara Hohlich; Armin Saalmuller; Eberhard Pfaff and Otfried Marquardt.

Appendix 17 - Serotyping of foot-and-mouth disease virus isolated from western buffer zone with coagglutination test as an alternative to CFT and ELISA, Gulner Unver and Feray Alkan.

Appendix 18 - Evaluation of a chromatographic strip test for foot-and-mouth disease virus antigen detection, Scott M. Reid; Anke Brunig; Nigel P. Ferris; Geoffrey H. Hutchings and Lennart Akerblom.

Appendix 19 - Development of antigen capture RT-PCR for foot-and-mouth disease virus antigen detection, Scott M. Reid; Geoffrey H. Hutchings and Nigel P. Ferris.

Appendix 20 - RT-PCR probing ELISAs for the diagnosis and typing of foot-and-mouth disease virus using our newly developed SNAP (Simple and Aqueous Phase) hybridization, Soren Alexandersen; Morag A. Forsythe; Scott M. Reid and Graham J. Belsham.

Appendix 21 - Evaluation of RT-PCR procedures for the diagnosis of clinical samples of foot-and-mouth disease virus (serotypes O, A, C and Asia 1) under EU Concerted Action PL 98-4032, Scott M. Reid; Geoffrey H.Hutchings; Nigel P. Ferris.

Appendix 22 - Diagnosis of persisting infections of foot-and-mouth disease virus in cattle: IgA ELISA, virus isolation and RT-PCR, P.Moonen; L. Jacobs; H. Costa; A. Crienen and R.S. Schrijver.

Appendix 23 - Spray-drying of inactivated FMDV antigens for diagnostic use, Amadori, M..

Appendix 24 - A solid phase competition ELISA for the detection of antibody to foot-and-mouth disease virus, N.P. Ferris; A.N.Bulut; T. Rendle; F. Davidson and D.K.J.Mackay.

Appendix 25 - Animal Production and Health Section of the Joint FAO/IAEA Programme of Nuclear Techniques in Agriculture (Vienna) Coordinated Research Project on: " The use of non-structural proteins of foot-and-mouth disease virus (FMDV)to differentiate between vaccinated and infected animals, J.R. Crowther.

Appendix 26 - Detection of antibodies against non-structural proteins of FMDV in Bulgaria, G. Georgiev, E. Veleva, A Dimitrova, Y. Ivanov.

Appendix 27 - Improved indirect ELISA based on the 3ABC polyprotein for differentiating infection from vaccination in foot-and-mouth disease, Esther Blanco; Marisa Arias and Jose Manuel Sanchez-Vizcaino.

Appendix 28 - Indirect ELISA using recombinant VP1 capsid protein for the serodifferentiation of foot-and-mouth disease virus infected animals, M. Wenger; J.D. Tratschin; M.A. Hofmann.

Appendix 29 - FAO Collaborative Study Phase XVI: Establishing reference standards for FMD serology, P.Kitching; T. Rendle and B. Newman.

Appendix 30 - Comparison of FMDV neutralization tests using three different cell lines: validation of the new FAO reference sera, P. Moonen; G.K.W. Miedema; F. van Hemert-Kluitenberg; G. Chenard and A. Dekker.

Appendix 31 - Longevity of the antibody response in pigs and sheep following a single administration of high potency emergency FMD vaccines, S.J. Cox and P.V. Barnett.

Appendix 32 - Enhancement of the immune response induced by the inclusion of saponine in oil adjuvanted vaccines against foot-and-mouth disease, E. Smitsaart; N. Mattion; J.L. Filippi; B. Robiolo; O. Periolo; J. La Torre and R.C. Bellinzoni.

Appendix 33 - Experimental vaccination against FMDV with immunocomplexes, H. Yadin; Dalia Chai; A. Bril; B. Gelman and M. Amadori.

Appendix 34 - Formaldehyde enhances BEI-inactivation rates of foot-and-mouth disease(FMD) virus by at least a ten-fold, Simon J. Barteling and Nazeem I. Cassim.

Appendix 35 - Validating the efficacy of emergency foot-and-mouth disease vaccines in sheep following virus challenge using the non-structural polyprotein 3ABC MAT-ELISA, Paul Barnett, Morag Forsyth and Sarah Cox.

Appendix 36 - Experimental FMD infections in pigs: a possible design for a PD50 experiment, Hanny Swam and Aldo Dekker.

Appendix 37 - The second report of the European Pharmacopoeia Working Group. Present and future contacts with the European Pharmacopoeia and with EMEA, Kris De Clercq (on behalf of the European Pharmacopoeia Working Group).

Appendix 38 - Preliminary results from the EUFMD Expert Elicitation Workshop on risk of introduction of FMD to Europe.John Ryan and Lisa Gallagher.

Appendix 39 - List of Participants

© European Commission for the Control of Foot-and-Mouth Disease

Back to Animal Health Pages